ACRES COMMERCIAL REALTY CORP (ACR) Fundamental Analysis & Valuation

NYSE:ACR • US00489Q1022

18.77 USD
+0.22 (+1.19%)
At close: Mar 3, 2026
18.77 USD
0 (0%)
After Hours: 3/3/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ACR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

ACR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 68 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. While ACR is still in line with the averages on profitability rating, there are concerns on its financial health. ACR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. ACR Profitability Analysis

1.1 Basic Checks

  • ACR had positive earnings in the past year.
  • In the past year ACR has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ACR reported negative net income in multiple years.
  • ACR had a positive operating cash flow in each of the past 5 years.
ACR Yearly Net Income VS EBIT VS OCF VS FCFACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

  • ACR's Return On Assets of 0.43% is in line compared to the rest of the industry. ACR outperforms 51.47% of its industry peers.
  • The Return On Equity of ACR (1.68%) is comparable to the rest of the industry.
  • ACR has a Return On Invested Capital of 0.60%. This is comparable to the rest of the industry: ACR outperforms 52.94% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACR is in line with the industry average of 1.22%.
  • The 3 year average ROIC (0.53%) for ACR is below the current ROIC(0.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.43%
ROE 1.68%
ROIC 0.6%
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ACR Yearly ROA, ROE, ROICACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • ACR has a Profit Margin (4.27%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ACR has declined.
  • Looking at the Operating Margin, with a value of 6.78%, ACR is doing worse than 69.12% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ACR has declined.
  • ACR has a Gross Margin of 43.97%. This is amongst the best in the industry. ACR outperforms 88.24% of its industry peers.
  • In the last couple of years the Gross Margin of ACR has remained more or less at the same level.
Industry RankSector Rank
OM 6.78%
PM (TTM) 4.27%
GM 43.97%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
ACR Yearly Profit, Operating, Gross MarginsACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ACR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACR is destroying value.
  • ACR has less shares outstanding than it did 1 year ago.
  • ACR has less shares outstanding than it did 5 years ago.
  • ACR has a better debt/assets ratio than last year.
ACR Yearly Shares OutstandingACR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACR Yearly Total Debt VS Total AssetsACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of -0.49, we must say that ACR is in the distress zone and has some risk of bankruptcy.
  • ACR has a Altman-Z score of -0.49. This is comparable to the rest of the industry: ACR outperforms 41.18% of its industry peers.
  • A Debt/Equity ratio of 2.48 is on the high side and indicates that ACR has dependencies on debt financing.
  • ACR has a better Debt to Equity ratio (2.48) than 80.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.48
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACC0.09
WACC6.8%
ACR Yearly LT Debt VS Equity VS FCFACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.36 indicates that ACR may have some problems paying its short term obligations.
  • ACR has a Current ratio of 0.36. This is in the better half of the industry: ACR outperforms 67.65% of its industry peers.
  • ACR has a Quick Ratio of 0.36. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ACR's Quick ratio of 0.36 is fine compared to the rest of the industry. ACR outperforms 67.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
ACR Yearly Current Assets VS Current LiabilitesACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ACR Growth Analysis

3.1 Past

  • The earnings per share for ACR have decreased strongly by -54.11% in the last year.
  • Measured over the past years, ACR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.41% on average per year.
  • The Revenue for ACR has decreased by -18.24% in the past year. This is quite bad
  • Measured over the past years, ACR shows a small growth in Revenue. The Revenue has been growing by 6.60% on average per year.
EPS 1Y (TTM)-54.11%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%320.83%
Revenue 1Y (TTM)-18.24%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%-5.89%

3.2 Future

  • The Earnings Per Share is expected to decrease by -21.10% on average over the next years. This is quite bad
  • Based on estimates for the next years, ACR will show a decrease in Revenue. The Revenue will decrease by -1.01% on average per year.
EPS Next Y-100.48%
EPS Next 2Y-21.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.81%
Revenue Next 2Y-1.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACR Yearly Revenue VS EstimatesACR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M 200M
ACR Yearly EPS VS EstimatesACR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. ACR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.01, the valuation of ACR can be described as expensive.
  • 73.53% of the companies in the same industry are cheaper than ACR, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, ACR is valued at the same level.
  • The Price/Forward Earnings ratio is 21.69, which indicates a rather expensive current valuation of ACR.
  • ACR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ACR is more expensive than 70.59% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.95, ACR is valued at the same level.
Industry RankSector Rank
PE 28.01
Fwd PE 21.69
ACR Price Earnings VS Forward Price EarningsACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ACR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACR is cheaper than 86.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 51.42
ACR Per share dataACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • A cheap valuation may be justified as ACR's earnings are expected to decrease with -21.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.1%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACR Dividend Analysis

5.1 Amount

  • No dividends for ACR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACR Fundamentals: All Metrics, Ratios and Statistics

ACRES COMMERCIAL REALTY CORP

NYSE:ACR (3/3/2026, 8:04:00 PM)

After market: 18.77 0 (0%)

18.77

+0.22 (+1.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)10-29
Earnings (Next)03-04
Inst Owners51.06%
Inst Owner Change26.09%
Ins Owners3.53%
Ins Owner Change0%
Market Cap136.83M
Revenue(TTM)170.34M
Net Income(TTM)7.28M
Analysts74.29
Price Target24.99 (33.14%)
Short Float %3.73%
Short Ratio7.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend2.58
Dividend Growth(5Y)-6.04%
DP295.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)387.51%
Min EPS beat(2)-77.37%
Max EPS beat(2)852.38%
EPS beat(4)2
Avg EPS beat(4)148.04%
Min EPS beat(4)-262.19%
Max EPS beat(4)852.38%
EPS beat(8)4
Avg EPS beat(8)63.93%
EPS beat(12)8
Avg EPS beat(12)53.82%
EPS beat(16)11
Avg EPS beat(16)42.04%
Revenue beat(2)1
Avg Revenue beat(2)0.3%
Min Revenue beat(2)-5.97%
Max Revenue beat(2)6.58%
Revenue beat(4)1
Avg Revenue beat(4)-6.43%
Min Revenue beat(4)-22.92%
Max Revenue beat(4)6.58%
Revenue beat(8)3
Avg Revenue beat(8)-2.89%
Revenue beat(12)7
Avg Revenue beat(12)17.79%
Revenue beat(16)11
Avg Revenue beat(16)47.89%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-34.92%
EPS NY rev (1m)0%
EPS NY rev (3m)93.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.14%
Valuation
Industry RankSector Rank
PE 28.01
Fwd PE 21.69
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA 51.42
EPS(TTM)0.67
EY3.57%
EPS(NY)0.87
Fwd EY4.61%
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS23.37
BVpS59.39
TBVpS58.5
PEG (NY)N/A
PEG (5Y)N/A
Graham Number29.92
Profitability
Industry RankSector Rank
ROA 0.43%
ROE 1.68%
ROCE 0.76%
ROIC 0.6%
ROICexc 0.62%
ROICexgc 0.63%
OM 6.78%
PM (TTM) 4.27%
GM 43.97%
FCFM N/A
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ROICexc(3y)0.55%
ROICexc(5y)N/A
ROICexgc(3y)0.55%
ROICexgc(5y)N/A
ROCE(3y)0.67%
ROCE(5y)N/A
ROICexgc growth 3Y-27.63%
ROICexgc growth 5Y-15.6%
ROICexc growth 3Y-27.72%
ROICexc growth 5Y-15.71%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 2.48
Debt/FCF N/A
Debt/EBITDA 43.08
Cap/Depr 36.83%
Cap/Sales 2.89%
Interest Coverage 0.13
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.49
F-Score5
WACC6.8%
ROIC/WACC0.09
Cap/Depr(3y)766.24%
Cap/Depr(5y)459.83%
Cap/Sales(3y)30.67%
Cap/Sales(5y)18.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.11%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%320.83%
EPS Next Y-100.48%
EPS Next 2Y-21.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.24%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%-5.89%
Revenue Next Year-3.81%
Revenue Next 2Y-1.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.91%
EBIT growth 3Y-34.93%
EBIT growth 5Y-21.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-141.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-102.92%
OCF growth 3Y-21.84%
OCF growth 5Y-14.85%

ACRES COMMERCIAL REALTY CORP / ACR FAQ

What is the ChartMill fundamental rating of ACRES COMMERCIAL REALTY CORP (ACR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ACR.


Can you provide the valuation status for ACRES COMMERCIAL REALTY CORP?

ChartMill assigns a valuation rating of 1 / 10 to ACRES COMMERCIAL REALTY CORP (ACR). This can be considered as Overvalued.


What is the profitability of ACR stock?

ACRES COMMERCIAL REALTY CORP (ACR) has a profitability rating of 4 / 10.


What is the valuation of ACRES COMMERCIAL REALTY CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ACRES COMMERCIAL REALTY CORP (ACR) is 28.01 and the Price/Book (PB) ratio is 0.32.


Can you provide the dividend sustainability for ACR stock?

The dividend rating of ACRES COMMERCIAL REALTY CORP (ACR) is 0 / 10 and the dividend payout ratio is 295.43%.